Atlas Venture’s Bruce Booth on testing the IPO waters and putting the ‘tech’ in biotech

Though the recent market slump has scared many biotechnology startups from initial public offerings, it hasn’t scared venture capitalists like Bruce Booth, a partner at Atlas Venture.